Læknablaðið - 15.12.1995, Side 29

LÆKNABLAÐIÐ 1995; 81
863
13. Mironov A. Decreased signal intensity of the putamen
and the caudate nucieus in Wilson disease of the brain.
Neuroradiology 1993; 35: 166.
14. Brugieres P, Combes C, Ricolfi F, Degos JD, Poirier J,
Gaston A. Atypical MR presentation of Wilson disease:
a possible consequence of paramagnetic effect of cop-
per? Neuroradiology 1992; 34: 222-4.
15. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson’s
disease: clinical presentation and use of prognostic in-
dex. Gut 1986; 27: 1377-81.
16. Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan
V, Brewer GJ. The psychiatric presentations of Wilson's
disease. J Neuropsych Clin Neurosci 1991; 3: 377-82.
17. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening
of neurologic syndrome in patients with Wilson’s disease
with initial penicillamine therapy. Arch Neurol 1987; 44:
490-3.
18. Brewer GJ, Turkay A, Yuzbasiyan-Gurkan V. Devel-
opment of neurologic symptoms in a patient with asymp-
tomatic Wilson's disease treated with penicillamine.
Arch Neurol 1994; 51: 304-5.